These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 2294257)
21. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876 [TBL] [Abstract][Full Text] [Related]
22. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
23. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study. Smith JA; Crawford ED; Paradelo JC; Blumenstein B; Herschman BR; Grossman HB; Christie DW J Urol; 1997 Mar; 157(3):805-7; discussion 807-8. PubMed ID: 9072571 [TBL] [Abstract][Full Text] [Related]
24. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431 [TBL] [Abstract][Full Text] [Related]
25. Radiation management of squamous cell carcinoma of the bladder. Prempree T; Amornmarn R Acta Radiol Oncol; 1984; 23(1):37-42. PubMed ID: 6328886 [TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186 [TBL] [Abstract][Full Text] [Related]
27. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy. Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849 [TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study. Martinez-Piñeiro JA; Gonzalez Martin M; Arocena F; Flores N; Roncero CR; Portillo JA; Escudero A; Jimenez Cruz F; Isorna S J Urol; 1995 Mar; 153(3 Pt 2):964-73. PubMed ID: 7853584 [TBL] [Abstract][Full Text] [Related]
29. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Soloway MS; Lopez AE; Patel J; Lu Y Cancer; 1994 Apr; 73(7):1926-31. PubMed ID: 8137219 [TBL] [Abstract][Full Text] [Related]
30. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577 [TBL] [Abstract][Full Text] [Related]
31. Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. Guo CC; Gomez E; Tamboli P; Bondaruk JE; Kamat A; Bassett R; Dinney CP; Czerniak BA Hum Pathol; 2009 Oct; 40(10):1448-52. PubMed ID: 19454359 [TBL] [Abstract][Full Text] [Related]
32. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. May M; Helke C; Nitzke T; Vogler H; Hoschke B Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349 [TBL] [Abstract][Full Text] [Related]